Actinium Pharmaceuticals
ATNM
#10565
Rank
S$44.29 M
Marketcap
S$1.41
Share price
1.85%
Change (1 day)
-32.54%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): S$12.51 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$35.09 Million. In 2025 the company made an earning of -S$46.42 Million, an increase over its 2024 earnings that were of -S$53.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$12.51 M-126.96%
2025 -S$46.42 Million-13.95%
2024 -S$53.95 Million-18.87%
2023 -S$66.5 Million52.24%
2022 -S$43.68 Million36.61%
2021 -S$31.98 Million11.48%
2020 -S$28.68 Million1.46%
2019 -S$28.27 Million-7.37%
2018 -S$30.52 Million-11.46%
2017 -S$34.47 Million10.67%
2016 -S$31.15 Million15.7%
2015 -S$26.92 Million-14.86%
2014 -S$31.62 Million129.19%
2013 -S$13.8 Million-8.55%
2012 -S$15.09 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-S$47.63 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.19 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA